- Country: Slovakia
- Summary: Dinutuximab 4.5 Mg/1 Ml, Infusion Concentrate
- SKT Ref No: 117549115
- Deadline: 19 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 902994.5
- Notice Type: Tender
- Document Ref. No.: 235813-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the order is a drug with the active substance Dinutuximab at a concentration of 4.5 mg/1ml; Infusion concentrate, supplement: Con info 4.5 ml/20 mg (drug. Inj. Skl).and have reached at least a partial response, followed by myelo -lablative treatment and stem cell transplantation, as well as in patients with a history of relaxed or refractory neuroblastoma with or without residual disease.
Treatment using this medicine consists of 5 cycles going behind,each cycle lasts 35 days. The individual dose is determined according to the body area and is intended to reach 100 mg/m2 per cycle.
Dinutuximab 4.5 mg/1 ml, infusion concentrate
The subject of the order is an active substance drugDinutuximab at a concentration of 4.5 mg/1ml; Infusion concentrate, supplement: Con info 4.5 ml/20 mg (drug. Inj. Skl).This was followed by myelo -lablative treatment and stem cell transplantation, as well as in patients with a history of related or refractory neuroblastoma with or without residual disease.
Treatment with this medicine consists of 5 cycles going behind, each cycle lasts 35 days.Individual ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDinutuximab 4.5 Mg/1 Ml, Infusion Concentrate - Slovakia Tender
The CHILDREN'S UNIVERSITY HOSPITAL WITH POLYCLINIC BANSKA BYSTRICA, a Government sector organization in Slovakia, has announced a new tender for Dinutuximab 4.5 Mg/1 Ml, Infusion Concentrate. This tender is published on SlovakiaTenders under SKT Ref No: 117549115 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-19.
The estimated tender value is EUR 902994.5, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
